Ceramic Biologics for Bony Fusion-a Journey from First to Third Generations
- PMID: 32562147
- PMCID: PMC7340712
- DOI: 10.1007/s12178-020-09651-x
Ceramic Biologics for Bony Fusion-a Journey from First to Third Generations
Abstract
Purpose of review: To provide information on characteristics and use of various ceramics in spine fusion and future directions.
Recent findings: In most recent years, focus has been shifted to the use of ceramics in minimally invasive surgeries or implementation of nanostructured surface modification features to promote osteoinductive properties. In addition, effort has been placed on the development of bioactive synthetics. Core characteristic of bioactive synthetics is that they undergo change to simulate a beneficial response within the bone. This change is based on chemical reaction and various chemical elements present in the bioactive ceramics. Recently, a synthetic 15-amino acid polypeptide bound to an anorganic bone material which mimics the cell-binding domain of type-I collagen opened a possibility for osteogenic and osteoinductive roles of this hybrid graft material. Ceramics have been present in the spine fusion arena for several decades; however, their use has been limited. The major obstacle in published literature is small sample size resulting in low evidence and a potential for bias. In addition, different physical and chemical properties of various ceramics further contribute to the limited evidence. Although ceramics have several disadvantages, they still hold a great promise as a value-based graft material with being easily available, relatively inexpensive, and non-immunogenic.
Keywords: Beta-tricalcium phosphate; Bioactive; Ceramics; Hydroxyapatite; Spine fusion; Synthetics.
Conflict of interest statement
No conflicts of interest for the current study. Disclosures outside of submitted work: Brandon Ortega, Carson Gardner, Sidney Roberts, and Andrew Chung have no disclosures. Jeffrey Wang: royalties—Biomet, Seaspine, Amedica, DePuy Synthes; investments/options—Bone Biologics, Pearldiver, Electrocore, Surgitech; board of directors—North American Spine Society, AO Foundation (20,000 honorariums for board position, plus travel for board meetings), Cervical Spine Research Society; editorial boards—Spine, the Spine Journal, Clinical Spine Surgery, Global Spine Journal; fellowship funding (paid directly to institution)—AO Foundation. Zorica Buser: consultancy—Cerapedics, The Scripps Research Institute, Xenco Medical (past), AO Spine (past); research support—SeaSpine (past, paid to the institution), Next Science (paid directly to institution), Motion Metrics (paid directly to institution); North American Spine Society—committee member; Lumbar Spine Society—co-chair research committee; AOSpine Knowledge Forum Degenerative—associate member; AOSNA Research Committee—committee member.
Figures
Similar articles
-
Use of hydroxyapatite in spine surgery.Eur Spine J. 2001 Oct;10 Suppl 2(Suppl 2):S197-204. doi: 10.1007/s005860100286. Eur Spine J. 2001. PMID: 11716019 Free PMC article. Review.
-
Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.Spine (Phila Pa 1976). 2002 Feb 15;27(4):353-60. doi: 10.1097/00007632-200202150-00006. Spine (Phila Pa 1976). 2002. PMID: 11840099
-
Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep.Spine J. 2014 Mar 1;14(3):435-44. doi: 10.1016/j.spinee.2013.09.048. Epub 2013 Oct 23. Spine J. 2014. PMID: 24438940
-
Comparative proteomic analysis of human mesenchymal stromal cell behavior on calcium phosphate ceramics with different osteoinductive potential.Mater Today Bio. 2020 Jun 24;7:100066. doi: 10.1016/j.mtbio.2020.100066. eCollection 2020 Jun. Mater Today Bio. 2020. PMID: 32642640 Free PMC article.
-
Ceramic and non-ceramic hydroxyapatite as a bone graft material: a brief review.Ir J Med Sci. 2015 Mar;184(1):101-6. doi: 10.1007/s11845-014-1199-8. Epub 2014 Nov 27. Ir J Med Sci. 2015. PMID: 25428698 Review.
Cited by
-
Novel Calcium Phosphate Promotes Interbody Bony Fusion in a Porcine Anterior Cervical Discectomy and Fusion Model.Spine (Phila Pa 1976). 2024 Sep 1;49(17):1179-1186. doi: 10.1097/BRS.0000000000004916. Epub 2024 Jan 12. Spine (Phila Pa 1976). 2024. PMID: 38213106 Free PMC article.
-
Prospective applications of bioactive materials in orthopedic therapies: A review.Heliyon. 2024 Aug 10;10(16):e36152. doi: 10.1016/j.heliyon.2024.e36152. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39247306 Free PMC article. Review.
-
Advances in Synthetic Grafts in Spinal Fusion Surgery.Int J Spine Surg. 2023 Dec 27;17(S3):S18-S27. doi: 10.14444/8557. Int J Spine Surg. 2023. PMID: 37748919 Free PMC article.
-
Understanding the Future Prospects of Synergizing Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery with Ceramics and Regenerative Cellular Therapies.Int J Mol Sci. 2021 Mar 31;22(7):3638. doi: 10.3390/ijms22073638. Int J Mol Sci. 2021. PMID: 33807361 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials